مروری بر مواد پیشرفته جهت رهایش تدریجی و آهسته دارو در بدن

1. Ezike TC, Okpala US, Onoja UL, Nwike CP,
Ezeako EC, Okpara OJ, et al. Advances in drug
delivery systems, challenges and future directions.
Heliyon. 2023;9(6):e17488-98. doi:10.1016/j.
heliyon.2023.e17488
2. Park K. Controlled drug delivery systems: past
forward and future back. J Control Release. 2014;
190:3-8. doi:10.1016/j.jconrel.2014.03.054
3. Claxton AJ, Cramer J, Pierce C. A systematic review
of the associations between dose regimens and
medication compliance. Clin Ther. 2001;23(8):
1296-310. doi:10.1016/s0149-2918(01)80109-0
4. Li J, Mooney DJ. Designing hydrogels for controlled
drug delivery. Nat Rev Mater. 2016;1(12):1-17.
doi:10.1038/natrevmats.2016.71
5. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit
R, Langer R. Nanocarriers as an emerging platform
for cancer therapy. Nat Nanotechnol. 2007;2(12):
751-60. doi:10.1038/nnano.2007.387
6. Allen TM, Cullis PR. Liposomal drug delivery
systems: from concept to clinical applications. Adv
Drug Deliv Rev. 2013;65(1):36-48. doi:10.1016/j.
addr.2012.09.037
7. Kataoka K, Harada A, Nagasaki Y. Block copolymer
micelles for drug delivery: design, characterization
and biological significance. Adv Drug Deliv Rev.
2001;47(1):113-31. doi:10.1016/s0169-409x(00)00
124-1
8. Kesharwani P, Jain K, Jain NK. Dendrimer as
nanocarrier for drug delivery. Progress in Polymer
Science. 2014;39(2):268-307. doi:10.1016/j.
progpolymsci.2013.07.005
9. Adepu S, Ramakrishna S. Controlled drug delivery
systems: current status and future directions.
Molecules. 2021;26(19):5905. doi:10.3390/
molecules26195905
10. Shabbani R, Badisar L, Moosavi R. A new
potentiomertic sensor for a preventing Alzheimer’s
disease drug based on nano-silver modified carbon
paste electrode. IJHSE. 2020;7:1444–9.
11. Karami A, Mohamed O, Ahmed A, Husseini GA,
Sabouni R. Recent advances in Metal-Organic
Frameworks as anticancer drug delivery systems: A
Review. Anticancer Agents Med Chem. 2021;
21(18):2487-504. doi:10.2174/18715206216662
10119093844
12. Boostani S, Jafari S. A comprehensive review on the
controlled release of encapsulated food ingredients;
fundamental concepts to design and applications.
Trend Food Sci Tech. 2021;109:303-21.
doi:10.1016./j.tifs.2021.01.040
13. Jain KK. An overview of drug delivery systems.
Drug Deliv Sys. 2019:1-54. doi:10.1007/978-1-
4939-9798-5_1
14. Glassman PM, Muzykantov VR. Pharmacokinetic
and pharmacodynamic properties of drug delivery
systems. J Pharm Exp Ther. 2019;370(3):570-80.
doi:10.1124/jpet.119.257113
15. Siegel RA. Stimuli sensitive polymers and self
regulated drug delivery systems: a very partial
review. J Control Release. 2014;190:337-51.
doi:10.1016/j.jconrel.2014.06.035
16. Peppas NA. Is there a future in glucose-sensitive,
responsive insulin delivery systems. J Drug Deliv
Sci Tech. 2004;14(4):247-56.
17. Yamashita F, Hashida M. Pharmacokinetic
considerations for targeted drug delivery. Adv Drug
Deliv Rev. 2013;65(1):139-47. doi:10.1016/j.
addr.2012.11.006
18. Almoshari Y. Osmotic pump drug delivery systemsA comprehensive review. Pharmaceuticals (Basel).
2022;15(11):1430. doi:10.3390/ph15111430
19. Prausnitz MR, Langer R. Transdermal drug delivery.
Nat Biotechnol. 2008;26(11):1261-8. doi:10.1038/
nbt.1504
20. Fayzullin A, Bakulina A, Mikaelyan K, Shekhter A,
Guller A. Implantable drug delivery systems and
foreign body reaction: Traversing the current clinical
landscape. Bioengineering (Basel). 2021;8(12)205.
doi:10.3390/bioengineering8120205
3126 / موسوی و همکاران
مجله طب نظامی دوره ،28 شماره ،1 فروردین و اردیبهشت 1405
21. Park H, Otte A, Park K. Evolution of drug delivery
systems: From 1950 to 2020 and beyond. J
Controlled Release. 2022;342:53-65. doi:10.1016/j.
jconrel.2021.12.030
22. Abrantes CG, Duarte D, Reis CP. An Overview of
Pharmaceutical Excipients: Safe or Not Safe?. J
Pharma Sci. 2016;105(7):2019-26. doi:10.1016/j.
xphs.2016.03.019
23. Ruiz-Picazo A, Lozoya-Agullo I, González-Álvarez
I, Bermejo M, González-Álvarez M. Effect of
excipients on oral absorption process according to
the different gastrointestinal segments. Exp Opin
Drug Deliv. 2021;18(8):1005-24. doi:10.1080/174
25247.2020.1813108
24. Afkhami A, Moosavi R, Madrakian T. Preconcen
tration and spectrophotometric determination of low
concentrations of malachite green and leucomalachite green in water samples by high
performance solid phase extraction using maghemite
nanoparticles. Talanta. 2010;82(1):785-9. doi:10.1
016/j.talanta.2010.05.054
25. Chen Q, Ji Y, Ge K. Influence of excipients on
thermodynamic phase behavior of pharmaceutical/
solvent systems: Molecular thermodynamic model
prediction. Chem Eng Sci. 2021;244:116798.
doi:10.1016/j.ces.2021.116798
26. Pockle RD, Masareddy RS, Patil AS, Patil PD. A
Comprehensive review on pharmaceutical
excipients. Therapeutic Deliv. 2023;14(7):443-58.
doi:10.4155/tde-2023-0026
27. Chen T, Ma Z, Qiu Z, Zhong Z, Xing L, Guo Q, et
al. Characterization of excipients to improve
pharmaceutical properties of sirolimus in the
supercritical anti-solvent fluidized process. Int J
Pharma. 2022;611:121240. doi:10.1016/j.ijpharm.
2021.121240
28. Thang NH, Chien TB, Cuong DX. Polymer-Based
Hydrogels Applied in Drug Delivery: An Overview.
Gels. 2023;9(7):523. doi:10.3390/gels9070523
29. Son GH, Lee BJ, Cho CW. Mechanisms of drug
release from advanced drug formulations such as
polymeric-based drug-delivery systems and lipid
nanoparticles. J Pharma Invest. 2017;47(4):287-96.
30. Siepmann J, Siegel RA, Rathbone MJ. Modeling of
diffusion controlled drug release, J Control Release.
2012;161(2):351-62. doi:10.1016/j.jconrel.2011.1
0.006
31. Moosavi R, Zibaseresht R, An improvement of
Ag/Fe3O4 nanoparticles probe for cyanide sensing.
RSC Adv. 2025;13:33120-8. doi:10.1039/D3RA06
654A
32. Liechty WB, Kryscio DR, Slaughter BV, Peppas
NA. Polymers for drug delivery systems. Annu Rev
Chem Biomol Eng. 2010;1:149-73. doi:10.1146/
annurev-chembioeng-073009-100847
33. Keraliya RA, Patel C, Patel P, Keraliya V, Soni TG,
Patel RC, et al. Osmotic drug delivery system as a
part of modified release dosage form. Int Scholar
Res Not. 2012;2012(1):528079. doi:10.5402/2012/
528079
34. Patil P, Uphade K, Saudagar R. A review: Osmotic
drug delivery system. Pharm Sci Monit. 2018;9(2):
283-300.
35. Patel J, Parikh S, Patel S. Comprehensive review on
osmotic drug delivery system. World J Pharm Res.
2021;10(5):523-5. doi:10.20959/wjpr20215-20303
36. Vigata M, Meinert C, Hutmacher DW, Bock N.
Hydrogels as Drug Delivery Systems: A Review of
Current Characterization and Evaluation
Techniques. Pharmaceutics. 2020;101(12):249-61.
doi:10.3390/pharmaceutics12121188
37. Liu B, Chen K. Advances in Hydrogel-Based Drug
Delivery Systems. Gels. 2024;10(4):262. doi:10.33
90/gels10040262
38. Narayanaswamy R, Torchilin VP. Hydrogels and
their applications in targeted drug delivery.
Molecules. 2019;24(3):603. doi:10.3390/molecules
24030603
39. Satish C, Satish K, Shivakumar H. Hydrogels as
controlled drug delivery systems: Synthesis,
crosslinking, water and drug transport mechanism.
Indian J Pharm Sci. 2006;68(2):133-40.
doi:10.4103/0250-474X.25706
40. Xin H, Naficy S. Drug delivery based on stimuliresponsive injectable hydrogels for breast cancer
therapy: a review. Gels. 2022;8(1):45. doi:10.33
90/gels8010045
41. Ma X, Sekhar KPC, Zhang P, Cui J. Advances in
stimuli-responsive injectable hydrogels for
biomedical applications. Biomater Sci. 2024;12(21):
5468-80. doi:10.1039/D4BM00956H
42. Mo C, Luo R, Chen Y. Advances in the StimuliResponsive Injectable Hydrogel for Controlled
Release of Drugs. Macromol Rapid Commun. 2022;
43(10):2200007. doi:10.1002/marc.202200007
43. Rizzo F, Kehr S. Recent Advances in injectable
hydrogels for controlled and local drug delivery.
Adv Health Mater. 2020;10(1):9843-64.
doi:10.1002/adhm.202001341
44. Dreiss CA. Hydrogel design strategies for drug
delivery. Curr Opin Col Interf Sci. 2020;48:1-17.
doi:10.1016/j.cocis.2020.02.001
45. Migdadi EM, Courtenay AJ, Tekko IA, McCrudden
MTC, Kearney MC, McAlister E, et al. Hydrogelforming microneedles enhance transdermal delivery
of metformin hydrochloride. J Control Release.
2018;285:142-51. doi:10.1016/j.jconrel.2018.07.0
09
46. Zhang Y, Wang J, Yu J, Wen D, Kahkoska AR, Lu
Y, et al. Bioresponsive Microneedles with a Sheath
Structure for H(2) O(2) and pH Cascade-Triggered
Insulin Delivery. Small. 2018;14(14):e1704181.
doi:10.1002/smll.201704181
47. Wang J, Ye Y, Yu J, Kahkoska AR, Zhang X, Wang
C, et al. Core-Shell microneedle gel for selfregulated insulin delivery. ACS Nano. 2018;12(3):
2466-73. doi:10.1021/acsnano.7b08152
48. Cho H, Jammalamadaka U, Tappa K, Egbulefu C,
Prior J, Tang R, et al. 3D Printing of poloxamer 407
nanogel discs and their applications in adjuvant
ovarian cancer therapy. Mol Pharm. 2019;16(2):
552-60. doi:10.1021/acs.molpharmaceut.8b00836
49. Shahid N, Erum A, Hanif S, Malik NS, Tulain UR,
Syed MA. Nanocomposite Hydrogels-A Promising
Approach towards Enhanced Bioavailability and
Controlled Drug Delivery. Curr Pharm Des.
رهایش تدریجی و آهسته دارو در بدن / 312۷
J Mil Med 2026, Volume 28, Issue 1
2024;30(1):48-62. doi:10.2174/0113816128283466
231219071151
50. Moosavi R, Afkhami A, Madrakian T. Maghemitenanoparticles enhanced effects in electrochemical
determination of dipyridamole utilizing
simultaneous statistical based experimental design
optimization. J. Electrochem. Soc. 2013; 160(10):
H775-H781. doi:10.1149/2.104310jes
51. Baishya G, Parasar B, Limboo M, Kumar R, Dutta
A, Hussain A, et al. Advancements in nanocomposite
hydrogels: a comprehensive review of biomedical
applications. Discover Materi. 2024;4(1):40.
doi:10.1007/s43939-024-00111-8
52. Valentino A, Yazdanpanah S, Conte R, Calarco A,
Peluso G. Smart nanocomposite hydrogels as nextgeneration therapeutic and diagnostic solutions.
Gels. 2024;10(11):689. doi:10.3390/gels10110689
53. Li X, Xu X, Xu M, Geng Z, Ji P, Liu Y. Hydrogel
systems for targeted cancer therapy. Front Bioeng
Biotechnol. 2023;11:1140436. doi:10.3389/fbioe.
2023.1140436
54. Tong S, Li Q, Liu Q, Song B, Wu J. Recent advances
of the nanocomposite hydrogel as a local drug
delivery for diabetic ulcers. Front Bioeng
Biotechnol. 2022;10:1039495. doi:10.3389/fbioe.
2022.1039495
55. Nafo W. Hydrogel Biomaterials for Drug Delivery:
Mechanisms, Design, and Drugs. J Drug Deliv Sci
Tech. 2022;75:103717. doi:10.5772/intechopen.
103156
56. Xie Y, Liu M, Cai C, Ye C, Guo T, Yang K, et al.
Recent progress of hydrogel-based local drug
delivery systems for postoperative radiotherapy.
Front Oncol. 2023;13:1027254. doi:10.3389/
fonc.2023.1027254
57. Jia Y, Jiang Y, He Y, Zhang W, Zou J, Magar KT, et
al. Approved Nanomedicine against Diseases.
Pharmaceutics. 2023;15(3):774. doi:10.3390/
pharmaceutics15030774
58. Liu P, Chen G, Zhang J. A review of liposomes as a
drug delivery system: current status of approved
products, regulatory environments, and future
perspectives. Molecules. 2022;27(4):1372. doi:10.3
390/molecules27041372
59. Luther DC, Huang R, Jeon T, Zhang X, Lee YW,
Nagaraj H, et al. Delivery of drugs, proteins, and
nucleic acids using inorganic nanoparticles. Adv
Drug Deliv Rev. 2020;156:188-213. doi:10.1016/
j.addr.2020.06.020
60. Moosavi R., Khajeh-Amiri A., Zibaseresht R.
Efficacy of Adsorption Processes Employing Green
Magnetic Nanocomposites for Benzoic Acid a Small
Contamination in Water. Chem Africa. 2025;8:
3663-76. doi:10.1007/s42250-025-01383-0
61. Thi TTH, Suys EJA, Lee JS, Nguyen DH, Park KD,
Truong NP. Lipid-Based Nanoparticles in the Clinic
and Clinical Trials: From Cancer Nanomedicine to
COVID-19 Vaccines. Vaccines (Basel). 2021;9(4):
359. doi:10.3390/vaccines9040359
62. Chen EC, Fathi AT, Brunner AM. Reformulating
acute myeloid leukemia: liposomal cytarabine and
daunorubicin (CPX-351) as an emerging therapy for
secondary AML. Onco Targets Ther. 2018;11:3425-
34. doi:10.2147/OTT.S141212
63. Puri A, Loomis K, Smith B, Lee JH, Yavlovich A,
Heldman E, et al. Lipid-based nanoparticles as
pharmaceutical drug carriers: from concepts to
clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):
523-80. doi:10.1615/critrevtherdrugcarriersyst.v2
6.i6.10
64. Alavi M, Karimi N, Safaei M. Application of various
types of liposomes in drug delivery systems. Adv
Pharm Bull. 2017;7(1):3-9. doi:10.15171/apb.201
7.002
65. Hou X, Zaks T, Langer R, Dong Y. Lipid
nanoparticles for mRNA delivery. Nat Rev Mater
2021;6(12):1078-94. doi:10.1038/s41578-021-
00358-0
66. Mohammadian Farsani A, Mokhtari N, Nooraei S,
Bahrulolum H, Akbari A, Farsani ZM, et al. Lipid
nanoparticles: The game-changer in CRISPR-Cas9
genome editing. Heliyon. 2024;10(2):e24606.
doi:10.1016/j.heliyon.2024.e24606
67. Luan F, He X, Zeng N. Tetrandrine: a review of its
anticancer potentials, clinical settings,
pharmacokinetics and drug delivery systems. J
Pharma Pharmaco. 2020;72(11):1491-512.
doi:10.1111/jphp.13339
68. Alvi M, Yaqoob A, Rehman K, Shoaib SM, Akash
MSH. PLGA-based nanoparticles for the treatment
of cancer: current strategies and perspectives. AAPS
Open. 2022;8(1):12. doi:10.1186/s41120-022-
00060-7
69. Negut I, Bita B. Polymeric Micellar Systems-A
Special Emphasis on "Smart" Drug Delivery.
Pharmaceutics. 2023;15(3)976. doi:10.3390/
pharmaceutics15030976
70. Wang J, Li B, Qiu L, Qiao X, Yang H. Dendrimerbased drug delivery systems: history, challenges,
and latest developments. J Biologic Eng.
2022;16(1):18. doi:10.1186/s13036-022-00298-5
71. Chauhan AS. Dendrimers for drug delivery.
Molecules. 2018;23(4):938. doi:10.3390/molecules
23040938
72. Luong D, Kesharwani P, Deshmukh R, Amin
MCIM, Gupta U, Greish K, et al. PEGylated
PAMAM dendrimers: Enhancing efficacy and
mitigating toxicity for effective anticancer drug and
gene delivery. Acta Biomaterialia. 2016;43:14-29.
doi:10.1016/j.actbio.2016.07.015
73. Scicluna MC, Vella-Zarb L. Evolution of
Nanocarrier Drug-Delivery Systems and Recent
Advancements in Covalent Organic Framework–
Drug Systems. ACS App Nano Mater. 2020;
3(4):3097-3115. doi:10.1021/acsanm.9b02603
74. Kooshki H, Abbaszadeh R, Heidari R, Akbariqomi
M, Mazloumi M et al, Developing a DNA aptamerbased approach for biosensing cystatin-c in serum:
An alternative to antibody-based methods. Materials
Adv. 2019;584(1):113386. doi:10.1016/j.ab.2019.
113386
75. Tian J, Han Z, Song D, Peng Y, Xiong M, Chen Z,
et al. Engineered Exosome for Drug Delivery:
Recent Development and Clinical Applications. Int
312۸ / موسوی و همکاران
مجله طب نظامی دوره ،28 شماره ،1 فروردین و اردیبهشت 1405
J Nanomedicine. 2023;18:7923-40. doi:10.2147/
IJN.S444582
76. Hashemi ZS, Ghavami M, Mohammadi F,
Shokrollahi Barough M, Shokati F, Asghari S, et al.
Doxorubicin-loaded NK exosomes enable
cytotoxicity against triple-negative breast cancer
spheroids. Iran J Basic Med Sci. 2024;27(12):1604-
15. doi:10.22038/ijbms.2024.79378.17194
77. Bunggulawa EJ, Wang W, Yin T, Wang N, Durkan
C, Wang Y, et al. Recent advancements in the use of
exosomes as drug delivery systems. J Nanobiotec.
2018;16(1):81. doi:10.1186/s12951-018-0403-9
78. Moosavi R, Ramanathan S, Lee YY, Chong Siew
Ling K, Afkhami A, Archunan G, et al. Synthesis of
antibacterial and magnetic nanocomposites by
decorating graphene oxide surface with metal
nanoparticles. RSC Adv. 2015;5:76442-50. doi:10.
1039/C5RA15578A
79. Moosavi R, Moussavi G. Faster accurate fluorometric
bio-sensing of E. coli by preconcentration on a
green-synthesized ag/Fe3O4/chitosan nanocomposite.
2023. doi:10.21203/rs.3.r s-3645682/v1
80. Yin Y, Hu B, Yuan X, Cai L, Gao H, Yang Q.
Nanogel: A Versatile Nano-Delivery System for
Biomedical Applications. Pharmaceutics. 2020;12
(3):290. doi:10.3390/pharmaceutics12030290
81. Shabbani R, Lackhay Rizi Z, Moosavi R. Selective
Potentiometric Sensor for Isoniazid Drug UltraTrace Determination” Int. J. Nanosci. Nanotechnol.
2018;14:241-9.
82. Shields IV CW, Wang LLW, Evans MA, Mitragotri
S. Materials for immunotherapy. Adv Mater. 2020;
32(13):1901633. doi:10.1002/adma.201901633
83. Katopodi T, Petanidis S, Floros G, Porpodis K,
Kosmidis C. Hybrid Nanogel Drug Delivery
Systems: Transforming the Tumor Microenvironment
through Tumor Tissue Editing. Cells. 2024;13(11):
908. doi:10.3390/cells13110908
84. Pattni BS, Chupin VV, Torchilin VP. New
Developments in Liposomal Drug Delivery. Chem
Rev. 2015;115(19):10938-66. doi:10.1021/acs.
chemrev.5b00046
85. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton
A, Préat V. PLGA-based nanoparticles: an overview
of biomedical applications. J Control Release. 2012;
161(2):505-22. doi:10.1016/j.jconrel.2012.01.043
86. Kumari A, Sharma PK, Garg VK, Garg G. Ocular
inserts - Advancement in therapy of eye diseases. J
Adv Pharm Technol Res. 2010;1(3):291-96.
doi:10.4103/0110-5558.72419
87. Mehnert W, Mäder K. Solid lipid nanoparticles:
production, characterization and applications. Adv
Drug Deliv Rev. 2001;47(2-3):165-96. doi:10.10
16/s0169-409x(01)00105-3
88. Müller RH, Radtke M, Wissing SA. Solid lipid
nanoparticles (SLN) and nanostructured lipid
carriers (NLC) in cosmetic and dermatological
preparations. Adv Drug Deliv Rev. 2002;54 Suppl
1:S131-55. doi:10.1016/s0169-409x(02)00118-7
89. Mora-Huertas CE, Fessi H, Elaissari A. Polymerbased nanocapsules for drug delivery. Int J Pharm.
2010;385(1-2):113-42. doi:10.1016/j.ijpharm.2009.
10.018
90. Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan
A. Poly-ϵ-caprolactone microspheres and
nanospheres: an overview. Int J Pharmac. 2004;
278(1):1-23. doi:10.1016/j.ijpharm.2004.01.044
91. Elsharkasy OM, Nordin JZ, Hagey DW, de Jong
OG, Schiffelers RM, Andaloussi SE, et al.
Extracellular vesicles as drug delivery systems: Why
and how?. Adv Drug Deliv Rev. 2020;159:332-43.
doi:10.1016/j.addr.2020.04.004
92. Luan X, Sansanaphongpricha K, Myers I, Chen H,
Yuan H, Sun D. Engineering exosomes as refined
biological nanoplatforms for drug delivery. Acta
Pharmacol Sin. 2017;38(6):754-63. doi:10.1038/
aps.2017.12
93. Mhettar P, Kale N, Pantwalawalkar J, Nangare S,
Jadhav N. Metal-organic frameworks: Drug delivery
applications and future prospects. ADMET and
DMPK. 2023;12(1):27-62. doi:10.5599/admet.2057
94. Horcajada P, Gref R, Baati T, Allan PK, Maurin G,
Couvreur P, et al. Metal-organic frameworks in
biomedicine. Chem Rev. 2012;112(2):1232-68.
doi:10.1021/cr200256v
95. Wang Y, Zhao Q, Han N, Bai L, Li J, Liu J, et al.
Mesoporous silica nanoparticles in drug delivery and
biomedical applications. Nanomedicine. 2015;11
(2):313-27. doi:10.1016/j.nano.2014.09.014
96. Dykman L, Khlebtsov N. Gold nanoparticles in
biomedical applications: recent advances and
perspectives. Chem Soc Rev. 2012;41(6):2256-82.
doi:10.1039/C1CS15166E
97. Huanbutta K, Puri V, Sharma A, Singh I,
Sriamornsak P, Sangnim T. Rise of implantable
drugs: A chronicle of breakthroughs in drug delivery
systems. Saudi Pharm J. 2024;32(12):102193.
doi:10.1016/j.jsps.2024.102193
98. He GQ, Li H, Liu J, Hu YL, Liu Y, Wang ZL, et al.
Recent Progress in Implantable Drug Delivery
Systems. Adv Mater. 2024;36(23):e2312530.
doi:10.1002/adma.20231253